Samsara BioCapital, 10% Owner: Mineralys Therapeutics MLYS Buy · Filed 25/03/17

Trade details

Type: Insider buy
Amount: $8,100,000
Shares · price: 600,000 sh · $13.50 a share
Held after: 5,674,916 sh
Stock: Mineralys Therapeutics MLYS
Person: Samsara BioCapital10% Owner
Trade date: 25/03/13
Filed: 25/03/17
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1.1 years
Last buy: 24/02/12
Insiders buying this week: 10 insiders
Holding change: +11.8%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Samsara BioCapital's recent trades

Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$281K
10,803 sh
$281K
Filed 24/11/27
Traded 24/11/26

Samsara BioCapital, 10% Owner — bought $8.1M of Mineralys Therapeutics MLYS · 600,000 sh @ $13.50 | Whalegun